Characterization of Two Novel Cell Lines, DERL-NK2 (CD56+/CD3+/TCRgd+) and DERL-NK7 (CD56+/CD3-/TCRgd-), Derived From a Single Patient With CD56+ Non-Hodgkin's Lymphoma